search: results update below
recently rated:
Rated by 2
1.8
$$$$$ Boston, US East
top rated funds:
Rated by 22
4.4
$$$$$ Boulder, US Central
Rated by 11
4.2
$$$$$ Austin, US West
Rated by 13
4.2
$$$$$ Santa Barbara, CA, US West
Rated by 20
4.1
$$$$$ Reston, US East
Rated by 10
3.9
$$$$$ Menlo Park, US West
Rated by 30
3.9
$$$$$ Menlo Park, US West
Rated by 40
3.9
$$$$$ Palo Alto, US West
Rated by 11
3.8
$$$$$ Luxembourg, Europe
Rated by 43
3.8
$$$$$ New York, US East
Rated by 32
3.8
$$$$$ Menlo Park, US West
Rated by 31
3.8
$$$$$ Boston, US East
Rated by 64
3.7
$$$$$ San Francisco, US West
Rated by 27
3.7
$$$$$ Palo Alto, US West
Rated by 105
3.7
$$$$$ Menlo Park, US West
Rated by 11
3.7
$$$$$ San Francisco, US West
Rated by 11
3.6
$$$$$ Santa Fe, US West
Rated by 20
3.6
$$$$$ Houston, US Central
Rated by 16
3.6
$$$$$ Menlo Park, US West
Rated by 10
3.6
$$$$$ Red Bank, US East
Rated by 62
3.6
$$$$$ Menlo Park, US West
Rated by 21
3.5
$$$$$ Munich, Europe
Rated by 12
3.5
$$$$$ London, Europe
Rated by 19
3.4
$$$$$ San Francisco, US West
Rated by 14
3.4
$$$$$ US West
Rated by 48
3.4
$$$$$ Menlo Park, US West
Rated by 31
3.4
$$$$$ Santa Monica, US West
Rated by 16
3.4
$$$$$ Menlo Park, US West
Rated by 11
3.4
$$$$$ Boston, US East
Rated by 10
3.4
$$$$$ London, Europe
Rated by 13
3.4
$$$$$ London, Europe
Please take a moment and make a financial contribution to TheFunded. If we have helped you, help us with resources to further grow the both the site and our entrepreneur training program, The Founder Institute.
AC Pharm Ltd CERTIFIED
Firm Rating:
Un-rated:
Track
Record
Operating
Competence
Pitching
Efficiency
Favorable
Deal Terms
Execution
Assistance
Firm Homepage:

FIRM OVERVIEW: Large Private VC founded in 2011 based out of London, UK (Europe)
FIRM DESCRIPTION: Our fund has been recently established and is currently seeking to complete its first major investment. AC Pharm is seeking to invest €10 -30 million in niche investment targets representing the highest growth potential in ready to market pharmaceutical technologies. It is hoped that the first round of significant capital allocations will be completed over the next 6 months.
We hope to work with smaller companies and entrepreneurial research facilities. Our aim is tohelp businesses to grow by providing financial resources at critical development phases. We act with integrity and respect for the people we deal with.
If you are seeking funding and would like to discuss this with us, please email us at investorrelations@ACPharm.com
TEAM MEMBERS:
David Heaney,
Nicholas Brocklebank,
Simona Kicova,